IFF Pharma Solutions Set to Highlight Its Portfolio at Excipient World 2025
IFF Pharma Solutions, a division of International Flavors & Fragrances Inc. and a global leader in polymer innovation, is preparing to take center stage at Excipient World 2025. Scheduled to be held from May 13–14 at the Gaylord National Resort and Convention Center in National Harbor, Maryland, USA, the event promises to be a landmark occasion for companies looking to advance their pharmaceutical excipient strategies. IFF will showcase a robust portfolio of sustainable solutions designed to transform pharmaceutical formulations, with special attention to innovations in controlled-release technologies and nitrosamine risk mitigation.
Visitors attending Excipient World can meet the IFF Pharma Solutions team at booth #205, where experts will demonstrate the company’s latest advancements in excipient development. With sustainability as a core driver of innovation, IFF aims to position itself not just as a solutions provider, but as a leader in the movement toward greener, safer, and more effective pharmaceutical ingredients.
“At IFF Pharma Solutions, we believe sustainability is not just a responsibility but an opportunity to innovate and inspire,” said Dr. Anne Adden, Global Strategic Marketing Director for Sustainability and Dietary Supplements at IFF. “We are committed to creating solutions that not only meet the needs of today’s pharmaceutical industry but also help shape a healthier, more sustainable future. Our team of problem-solvers and experts is redefining what it means to lead in sustainable healthcare.”
A Legacy of Innovation, Reimagined for Today’s Challenges
Building on a proud legacy of more than 75 years of expertise in polymer science, IFF Pharma Solutions continues to redefine what is possible in pharmaceutical formulation. The company’s extensive excipient portfolio remains at the forefront of innovation, offering formulators high-performance solutions to meet the evolving needs of the pharmaceutical market.
At Excipient World 2025, IFF will highlight several of its flagship brands:
- METHOCEL™: A cornerstone of controlled-release drug delivery for decades, METHOCEL™ cellulose ethers continue to evolve. Today, the brand is known not only for its reliable performance but also for its new sustainable and low-nitrite options, developed to reduce impurity risks in drug formulations.
- ETHOCEL™: With a track record of proven performance, ETHOCEL™ ethylcellulose polymers enable formulators to achieve sustained drug release and protect active ingredients. Its versatility in both aqueous and solvent-based systems makes it a trusted choice for formulators worldwide.
- POLYOX™: Known for its high versatility, POLYOX™ water-soluble polymers serve a wide variety of applications, from controlled drug release to taste masking. Its ability to form gels, films, and tablets offers unique functional advantages across complex formulation challenges.
A Focus on Nitrosamine Risk Mitigation
Among the innovations being introduced, particular attention will be given to IFF’s new Low Nitrite METHOCEL™ HPMC and Avicel® PH LN co-processed microcrystalline cellulose products. Both of these cutting-edge materials have been specially engineered to help reduce the formation of nitrosamines, carcinogenic compounds that have become a major regulatory concern in recent years.
Nitrosamine impurities have led to widespread recalls and heightened regulatory scrutiny across the pharmaceutical industry. By proactively developing excipients with reduced nitrite levels, IFF Pharma Solutions is offering manufacturers critical tools to design safer drug products. These solutions reflect IFF’s commitment to staying ahead of regulatory expectations and ensuring patient safety without compromising formulation performance.
“Our focus on nitrosamine mitigation is part of a broader commitment to proactive risk management and quality assurance,” added Dr. Adden. “We understand the challenges pharmaceutical companies face, and we are delivering solutions that not only solve today’s problems but also anticipate tomorrow’s regulatory and scientific expectations.”
Sustainable by Design: A Philosophy, Not Just a Goal
Central to IFF’s activities at Excipient World 2025 will be a presentation by Dr. Anne Adden titled “Sustainable by Design: The Future of Excipients”. Scheduled for May 13 from 2:00 PM to 2:45 PM ET in the Riverview Ballroom, Stage 2, Dr. Adden’s talk will delve deep into how IFF is embedding sustainability at every stage of excipient development—from raw material sourcing to production methods, and from product performance to end-of-life considerations like packaging and biodegradability.
Attendees can expect an in-depth look at how IFF integrates eco-design principles into its innovation pipeline, ensuring that sustainability is not an afterthought but a guiding principle. The session will also highlight case studies where sustainable excipient solutions have successfully supported customers’ green initiatives and corporate social responsibility (CSR) goals.
“We don’t see sustainability as a box to check,” said Dr. Adden. “It’s embedded into the DNA of everything we do, from R&D to commercialization. Our mission is to help customers make better, more sustainable choices without sacrificing efficacy, quality, or regulatory compliance.”
Engaging with the Future of Healthcare
IFF’s participation at Excipient World 2025 underscores its broader commitment to advancing health and wellness through science, innovation, and responsible business practices. In addition to showcasing their technical capabilities, the IFF Pharma Solutions team is eager to engage with formulators, regulatory experts, supply chain partners, and thought leaders to explore how collaboration can drive the future of pharmaceutical excipients.
“We view Excipient World not just as a platform to present our innovations, but as a catalyst for industry-wide collaboration,” said Dr. Adden. “We want to work hand-in-hand with partners who share our vision for a more sustainable, resilient, and patient-centered pharmaceutical industry.”
About IFF Pharma Solutions
IFF Pharma Solutions is a global leader in pharmaceutical excipient innovation, offering one of the industry’s broadest and most trusted portfolios of polymers and delivery solutions. Leveraging decades of experience in cellulosic and polyethylene oxide chemistries, IFF provides advanced formulation solutions that enable drug manufacturers to enhance the performance, safety, and sustainability of their products.
Operating at the intersection of science and sustainability, IFF Pharma Solutions is committed to delivering innovations that improve lives while respecting the planet’s resources.
As the pharmaceutical landscape continues to evolve—with increasing demands for safer, more effective, and more sustainable drug products—excipient innovation will play a critical role in meeting these challenges. IFF Pharma Solutions’ appearance at Excipient World 2025 signals a clear intent to lead the industry into this new era, setting new benchmarks for technical excellence, regulatory foresight, and environmental stewardship.
Those attending Excipient World 2025 are encouraged to visit booth #205 to experience firsthand how IFF Pharma Solutions is shaping the future of excipient technology, and to join Dr. Adden’s presentation to gain insights into how sustainability can be seamlessly integrated into pharmaceutical formulation practices.
